N

09887

Nanjing Leads Biolabs

76.65

-1.15-1.48%
Closed16:08 07/30 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE75.850/77.800
TODAY RANGE73.950-83.600
VOL4.68M
MARKET CAP14.82B
52 WEEK RANGE63.200-83.600
AVG VOL (3M)11.58M
% TURNOVER2.42%
TURNOVER369.94M
P/E (TTM)-47.161
% RANGE12.40%
EPS(TTM)-1.625
P/E(FORWARD)--
P/B70.992
BVPS1.080
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.14B
SHARES OUTSTANDING193.36M
NEXT EARNINGS--
FREE FLOAT132.27M
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
    Same Industry
    Name/Symbol
    Change%
    Price

    S

    Shanghai Haohai Biological Technology

    06826

    -2.18%
    29.100

    W

    Wuxi Apptec

    02359

    +0.27%
    112.000

    H

    Hangzhou Tigermed Consulting

    03347

    -2.73%
    57.000

    J

    JOINN Laboratories (China)

    06127

    -8.94%
    25.450

    P

    Pharmaron Beijing

    03759

    -4.81%
    23.750

    F

    Frontage Holdings

    01521

    -6.21%
    1.660

    B

    BBI Life Sciences

    01035

    0.00%
    3.490

    C

    China Health Group

    08225

    -1.64%
    0.180

    M

    Mingyuan Medicare Development

    00233

    0.00%
    0.230

    C

    China Regenerative Medicine International

    08572

    --
    0.010

    M

    Mabpharm

    02181

    -5.26%
    0.540

    V

    Viva Biotech Holdings

    01873

    0.00%
    1.750

    C

    China Regenerative Medicine International

    08158

    +50.85%
    0.890

    B

    BioDlink International

    01875

    -0.36%
    2.740

    H

    Hua Medicine

    02552

    -5.88%
    3.680

    M

    MicroPort NeuroScientific

    02172

    +7.27%
    14.460

    A

    Alphamab Oncology

    09966

    +8.79%
    10.400

    S

    SinoMab BioScience

    03681

    -3.56%
    3.520

    L

    Lepu Biopharma

    02157

    -4.10%
    7.710

    J

    Jacobio Pharmaceuticals Group

    01167

    +13.22%
    8.820
    Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
    During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
    Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
    Language

    English

    ©2025 Webull Securities Limited. All rights reserved.